Reining in drug costs

8:43 AM ET Tue, 22 Sept 2015

American Enterprise Institute's Scott Gottlieb, M.D., comments on survival rates for Lymphoma. Also Gottlieb provides perspective on the impact of expiring patents on competition in the pharmaceutical industry.